Recovery Phase Matching — Acute Injury vs Chronic Overtraining
Recovery isn't a single biological state. It's at least three mechanistically distinct phases, and CJC-1295 ipamorelin protocol recovery efficacy depends entirely on matching peptide intervention to the correct phase. Acute injury recovery (days 0–7 post-traum
This comparison does not assign a generated winner or score.
- Recovery isn't a single biological state. It's at least three mechanistically distinct phases, and CJC-1295 ipamorelin protocol recovery efficacy depends entirely on matching peptide intervention to the correct phase. Acute injury recovery (days 0–7 post-trauma) is dominated by inflammation resolution and initial collagen scaffold deposition. GH's role here is indirect, mediated through IGF-1 stimulation of fibroblast proliferation and Type I collagen synthesis. Chronic tissue remodeling (weeks 2–8) shifts toward collagen cross-linking, scar tissue minimization, and functional tissue architecture restoration. This is where sustained IGF-1 elevation matters most.
- Overtraining recovery is biochemically different from injury recovery. Overtraining syndrome involves blunted hypothalamic-pituitary-adrenal (HPA) axis function, suppressed endogenous GH pulsatility (often 40–60% reduction in nocturnal GH peaks), and impaired peripheral IGF-1 receptor sensitivity despite normal circulating IGF-1 levels. CJC-1295 ipamorelin protocol recovery addresses the central suppression. Restoring pituitary GH secretory capacity. But doesn't fix receptor-level IGF-1 resistance, which requires deloading and nutrient repletion first. Starting a peptide protocol during active overtraining without addressing the underlying HPA dysfunction produces minimal benefit because the tissue can't respond to the elevated hormone signal.
- Protocol selection rule: acute injury or post-surgical recovery responds best to 6–8 week cycles with CJC-1295 dosed twice weekly (Monday/Thursday) plus daily ipamorelin before bed. Chronic overtraining recovery requires a 2–week complete training cessation period before initiating peptides, then an 8–12 week protocol with CJC-1295 once weekly and ipamorelin 5 days per week (skipping weekends to preserve pulsatility). The difference matters. A 2019 study in the Journal of Applied Physiology found that GH secretagogue protocols initiated during active overtraining showed zero improvement in muscle protein synthesis rates versus placebo, while the same protocol initiated after 2 weeks' rest produced measurable increases in Type I and Type IIa fiber cross-sectional area.